↓ Skip to main content

Rivaroxaban compared to no treatment in ER-negative stage I–III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised…

Overview of attention for article published in Trials, August 2020
Altmetric Badge

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
58 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rivaroxaban compared to no treatment in ER-negative stage I–III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial
Published in
Trials, August 2020
DOI 10.1186/s13063-020-04675-7
Pubmed ID
Authors

John Castle, Emma Blower, Nigel J. Bundred, James R. Harvey, Jecko Thachil, Andrea Marshall, Karina Cox, Silvia Cicconi, Chris Holcombe, Carlos Palmieri, Cliona C. Kirwan

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 58 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 9%
Student > Ph. D. Student 5 9%
Student > Master 3 5%
Student > Bachelor 2 3%
Unspecified 2 3%
Other 6 10%
Unknown 35 60%
Readers by discipline Count As %
Medicine and Dentistry 12 21%
Nursing and Health Professions 3 5%
Unspecified 2 3%
Biochemistry, Genetics and Molecular Biology 2 3%
Neuroscience 2 3%
Other 2 3%
Unknown 35 60%